Society of Nuclear Medicine and Molecular Imaging (SNMMI)’s Post

Exciting News for Nuclear Medicine! A new rule proposes to unbundle diagnostic radiopharmaceuticals from the current payment system, classifying them separately from "supplies." This will prevent CMS from overpaying for low-cost diagnostics and offer patients access to advanced imaging agents. #nuclearmedicine #radiologynews #healthcare #compuraymedical

Time to comment has started! Let’s do this! Long time coming, and significant amount of lobbying to get us to this point. Kudos!! 🤞🤞🤞🤞🤞🤞🤞🤞🤞 #radiopharmaceuticals #nuclearmedicine #theranostics #radioligandtherapy #radiology #precisionmedicine

https://lnkd.in/gpcgbK4E Key Insights: • The FARAPULSE PFA System offers a unique approach, utilizing tissue-selective, non-thermal electric fields for heart tissue ablation, avoiding damage to surrounding structures during the procedure Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #drugapproval #HealthTrends #Insights #HealthIndustry #HealthInnovation #bostonscientific #devices #medicaldevices #HealthcareAnalytics #NewsUpdate #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights

https://lnkd.in/gpcgbK4E Key Insights: • The FARAPULSE PFA System offers a unique approach, utilizing tissue-selective, non-thermal electric fields for heart tissue ablation, avoiding damage to surrounding structures during the procedure Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #drugapproval #HealthTrends #Insights #HealthIndustry #HealthInnovation #bostonscientific #devices #HealthcareAnalytics #NewsUpdate #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights

What steps will you take to ensure your new, innovative radiopharmaceutical delivers on its clinical promise and achieves successful commercial adoption? We've got some suggestions. Tune in to Fractals: Life Science Conversations with guest Andrew Beck to unravel the mysteries of the radiopharmaceutical 'unk-unk', understand the significance of patient education in sales, and learn why an integrated approach is pivotal for effective strategy. https://lnkd.in/gspsAYfq #Radiopharmaceuticals #CommercializationStrategy #LifeSci #Bracken

Vivos Therapeutics (NASDAQ:VVOS) CEO Kirk Huntsman joined Steve Darling from Proactive to highlight certain significant favorable market developments creating new opportunities to widen its funnel of potential users of Vivos’ oral appliance therapies. This after the U.S. FDA granted, for the first time ever, a clearance to the Vivos CARE appliances to treat moderate and severe OSA in adults, 18 years of age and older along with positive airway pressure and/or myofunctional therapy, as needed. Huntsman highlighted several other factors contributing to the positive market conditions for Vivos. The recent discontinuation of many devices by Philips Respironics is expected to disrupt the supply chain, potentially affecting patient care. Additionally, the recalls of continuous positive airway pressure (CPAP) devices have left millions of OSA sufferers searching for alternative treatments. Watch at #Proactive #ProactiveInvestors #NASDAQ #VVOS http://ow.ly/pOWb105fGlO

Expanding the horizon of TB diagnosis

BD has a long history in TB diagnostics, having launched the first automated liquid culture system, the BD BACTEC™ MGIT™ Automated Mycobacterial Detection System for comprehensive testing for TB, drug susceptibility and monitoring patients' response to treatment. The WHO supported BD MAX™ MDR-TB Assay complements this technology enabling clinicians to rapidly test for TB and multidrug resistance as a first-line test and then use the BD BACTEC™ MGIT™ System for broader drug susceptibility testing and patient monitoring. Please click here to know more : https://lnkd.in/gNeQMmer #BDIndia #YesWeCanEndTB, #MGITComplete #TBHaregaDeshJeetega Disclaimer: The information provided herein is not meant to be used, nor should it be used, to diagnose or treat any medical condition. All content, including text, graphics, images and information etc., contained in or available through this literature is for general information purposes only. For diagnosis or treatment of any medical condition, please consult your physician/doctor. Becton Dickinson India Private Limited and or its affiliates, its employees are not liable for any damages/claims to any person in any manner whatsoever. BD-84954 BD-103890

Why is the IVDR timeline so long? Under the European Union In Vitro Diagnostics Directive 98/79/EC (IVD-D), approximately 8% of IVDs required Notified Body involvement. Under European Union In Vitro Diagnostics Regulation 2017/746 (EU IVDR), approximately 80% of IVDs require Notified Body involvement. Given that there are 34,000 companies within the European medical device sector, and only 36 designated notified bodies for IVDR, the limited capacity of the notified bodies plus a slower than expected uptake and recognition of the regulation has contributed to the protracted timelines of the transition to this point. If you have any questions about IVDR, please contact [email protected] to speak to an expert #DPYD #IVDR #DPYDGenotyping #PrecisionMedicine #Pharmacogenomics

Datapoint: FDA Approves Lilly’s New Alzheimer’s Drug: The FDA on July 2 granted full approval to Eli Lilly’s Kisunla (donanemab) for the treatment of Alzheimer’s disease. The new therapy joins Eisai and Biogen’s Leqembi (lecanemab) in the burgeoning Alzheimer’s market basket. The two drugs’ in... Read More #marketaccess #lifesciences #pbm